Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.

Shi X, Wang JH, Chapin BF, Aparicio A, Subudhi SK, Tran PT, Park RJ, Deek MP, Zhang H, Bylund KC, Cummings M, Armstrong AJ, Tang C, Sutera P

Open source

DOI: 10.1038/s41391-025-01041-z
Published: 2026 Jun
Container: Prostate cancer and prostatic diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41391-025-01041-z,
  title = {Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.},
  author = {Shi X and Wang JH and Chapin BF and Aparicio A and Subudhi SK and Tran PT and Park RJ and Deek MP and Zhang H and Bylund KC and Cummings M and Armstrong AJ and Tang C and Sutera P},
  year = {2026},
  journal = {Prostate cancer and prostatic diseases},
  doi = {10.1038/s41391-025-01041-z},
  url = {https://doi.org/10.1038/s41391-025-01041-z}
}

RIS

TY  - JOUR
TI  - Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.
AU  - Shi X
AU  - Wang JH
AU  - Chapin BF
AU  - Aparicio A
AU  - Subudhi SK
AU  - Tran PT
AU  - Park RJ
AU  - Deek MP
AU  - Zhang H
AU  - Bylund KC
AU  - Cummings M
AU  - Armstrong AJ
AU  - Tang C
AU  - Sutera P
PY  - 2026
JO  - Prostate cancer and prostatic diseases
DO  - 10.1038/s41391-025-01041-z
UR  - https://doi.org/10.1038/s41391-025-01041-z
ER  -

APA

X, S., JH, W., BF, C., A, A., SK, S., PT, T., RJ, P., MP, D., H, Z., KC, B., M, C., AJ, A., C, T., & P, S. (2026). Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.. Prostate cancer and prostatic diseases. https://doi.org/10.1038/s41391-025-01041-z

Source records

pubmed · retrieved 2026-09-26T12:39:07.004Z